Westside Investment Management’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1
| Closed | -$5 | – | 1545 |
|
|
2025
Q3 | $5 | Hold |
1
| – | – | ﹤0.01% | 1378 |
|
|
2025
Q2 | $4 | Hold |
1
| – | – | ﹤0.01% | 1281 |
|
|
2025
Q1 | $4 | Hold |
1
| – | – | ﹤0.01% | 976 |
|
|
2024
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 984 |
|
|
2024
Q3 | $5 | Hold |
1
| – | – | ﹤0.01% | 987 |
|
|
2024
Q2 | $6 | Hold |
1
| – | – | ﹤0.01% | 981 |
|
|
2024
Q1 | $7 | Buy |
+1
| New | +$7 | ﹤0.01% | 897 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 866 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 839 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 838 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 837 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 854 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 851 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 837 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 817 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 794 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 766 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 759 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 749 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 679 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 659 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 646 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 659 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 677 |
|
|
2018
Q4 | $522 | Hold |
1
| – | – | ﹤0.01% | 666 |
|
|
2018
Q3 | $491 | Hold |
1
| – | – | ﹤0.01% | 715 |
|
|
2018
Q2 | $3.06K | Hold |
1
| – | – | ﹤0.01% | 734 |
|
|
2018
Q1 | $2.89K | Hold |
1
| – | – | ﹤0.01% | 737 |
|
|
2017
Q4 | $4.04K | Hold |
1
| – | – | ﹤0.01% | 710 |
|
|
2017
Q3 | $6.93K | Hold |
1
| – | – | ﹤0.01% | 623 |
|
|
2017
Q2 | $5.85K | Hold |
1
| – | – | ﹤0.01% | 634 |
|
|
2017
Q1 | $9.16K | Hold |
1
| – | – | ﹤0.01% | 528 |
|
|
2016
Q4 | $7.72K | Buy |
+1
| New | +$16.8K | 0.01% | 456 |
|
Other funds holding TTNP
CA
GWSA
CSC
DJSG
Westside Investment Management's TTNP Position: Q4 2025 in Review
Westside Investment Management sold out of Titan Pharmaceuticals (TTNP) in Q4 2025, closing a stake of 1 share — an estimated $5 sold.
Westside Investment Management first reported a position in TTNP in Q4 2016 and held it in 16 quarters. The position peaked at $9.16K in Q1 2017. 4 funds tracked by Wall St. Rank hold TTNP as of Q4 2025.
- Westside Investment Management reported no remaining Titan Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Westside Investment Management sold 1 Titan Pharmaceuticals share in Q4 2025, an estimated $5.
- Westside Investment Management first reported a position in Titan Pharmaceuticals in Q4 2016 and held it in 16 quarters.
- Westside Investment Management's Titan Pharmaceuticals position peaked at $9.16K in Q1 2017.
- 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2025.
Based on Westside Investment Management's 13F filing for Q4 2025, filed 23 Jan 2026.